Oncology Books

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Book Synopsis

Read more less

Book SynopsisOne in two of us will develop cancer at some point in our lives and yet many of us don''t understand how cancers arise. How many different kinds of cancer are there? What treatments are available? What does the future hold in terms of developing new therapies? This book demystifies cancer by explaining the underlying cell and molecular biology in a clear and accessible style. It answers the questions commonly asked about cancer such as what causes cancer and how cancer develops. It explains how DNA makes proteins and how mutations can corrupt those proteins. It also gives an overview of current therapies and how treatments may advance over the next decades, as well as explaining what actions we can take to help prevent cancer developing. Understanding Cancer is an accessible and engaging introduction to cancer biology for any interested reader.Trade Review'How often have we attended a lecture or opened a book to find that within minutes we are smothered by complicated facts that are way beyond our understanding? There has been no simple introduction. The speaker/author is so involved in the topic that they could no longer see out of the intellectual hole that they had dug for themselves. If ever a book was written to dispel this fault, then this is the one, as Robin Hesketh has managed to provide a remarkably clear and readable account of the science behind cellular behaviour and faults that lead to the development of cancer. The book reads like a novel, and I found that I could hardly put it down. The literary style is at times light-hearted with humorous analogies.' Robert Whitaker, anatomist, University of Cambridge'Understanding Cancer presents a carefully crafted, clear and concise book on aspects of cancer; a disease of importance to us all. Most readers will come to Robin Hesketh's book with questions about cancer. Understanding Cancer will not disappoint. The most usual questions and answers are presented in the first chapter and ways of reducing the risk of some cancers are suggested later. This book puts cancer into a historical and very interesting context; it then explores cancer, its biochemistry and functioning in an approachable way. Information is given about the latest treatments and the science behind them. This very readable book contains something for everyone. It is positioned, and very adequately fills, the gap between personal accounts by patients of their experiences, and more advanced medical and cell biology texts. Understanding Cancer is well researched and greatly recommended.' David Archer, schools liaison officer, British Society for Cell Biology'Understanding Cancer is a fascinating and engaging perspective on the evolution of cancer research and treatment. Dr Hesketh provides insight into the key clinicians and scientists, following their discoveries in clinical care and research. He overviews the likely mutagenic causes of cancer spurring on the oncogenic transitions leading to a cancer cell that can replicate uncontrollably, highlights new avenues in cancer research, and conveys that preventive measures and advances in early cancer detection could make an impact on cancer incidence and patient outcomes/survival. This book is certainly a triumph and a must-read for all current and future scientists, physicians at any stage of their professional careers and anyone interested in cancer research and the quest for effective anti-cancer treatments.' David Lyden, David Lyden, cancer researcher and paediatric oncologist, Weill Cornell Medicine, Cornell UniversityTable of Contents1. Painting a clear picture; 2. Ancient history; 3. Counting cancer; 4. From DNA to protein; 5. What is a cell?; 6. Mutations; 7. Causes of cancer that can be controlled; 8. Causes of cancer that are difficult to control, accidents … and other things; 9. Treating cancer by chemotherapy; 10. The road to utopia?

Read more less

Book SynopsisSurface Guided Radiation Therapy provides a comprehensive overview of optical surface image guidance systems for radiation therapy. It serves as an introductory teaching resource for students and trainees, and a valuable reference for medical physicists, physicians, radiation therapists, and administrators who wish to incorporate surface guided radiation therapy (SGRT) into their clinical practice. This is the first book dedicated to the principles and practice of SGRT, featuring: Chapters authored by an internationally represented list of physicists, radiation oncologists and therapists, edited by pioneers and experts in SGRT Covering the evolution of localization systems and their role in quality and safety, current SGRT systems, practical guides to commissioning and quality assurance, clinical applications by anatomic site, and emerging topics including skin mark-less setups. Several dedicated chapters on SGRT Trade Review“This book provides comprehensive, technically orientated information of surface guided radiation therapy, a rapidly emerging technology in radiotherapy. Authored by medical physicists, radiation therapists, and radiation vendors, this book covers all aspects of surface guided radiation therapy, with the intention of this new technology being implemented clinically in a safe and efficient manner. The book will likely be of greatest interest to residents of medical physics and radiation oncology as a textbook to gain general knowledge in the field, as well as to medical physicists as a reference book when implementing this new technology clinically. It may also be of interest to administration professionals who are considering expanding clinical practice and would like a general overview. This book is a timely addition to radiotherapy literature with a comprehensive collection of information and knowledge that has been gained in this emerging new field. While there are many research publications about surface guided radiotherapy already, this is the first book that encompasses technical information related to current SGRT systems on the market.” —Shuying Wan, PhD (Sidney Kimmel Cancer Center-Thomas Jefferson University) in Doody’s Core Titles Review 2022. Table of ContentsContents Preface, xi Acknowledgments, xiii Contributors, xv Chapter 1 ◾ A History of Surface Guidance Methods in Radiation Therapy 1 Jeremy D. P. Hoisak and Todd Pawlicki Chapter 2 ◾ Safety and Quality Improvements with SGRT 25 Hania A. Al-Hallaq and Bill J. Salter Chapter 3 ◾ Technical Overview and Features of the C-RAD Catalyst™ and Sentinel™ Systems 51 Karl Rasmussen, Victoria Bry, and Nikos Papanikolaou Chapter 4 ◾ Technical Overview and Features of the Varian IDENTIFY ™ System 73 Raymond Schulz, Chris Huyghe, Lisa Hampton, Delena Hanson, Michael stead, and Thomas Speck Chapter 5 ◾ Technical Overview and Features of the Vision RT AlignRT® System 95 Benjamin Waghorn Chapter 6 ◾ Commissioning and Routine Quality Assurance of the C-RAD Catalyst™ and Sentinel™ 4D-CT Systems 117 Alonso N. Gutierrez and Dennis N. Stanley Chapter 7 ◾ Commissioning and Routine Quality Assurance of the Varian IDENTIFY ™ System 137 Hui Zhao and Adam B. Paxton Chapter 8 ◾ Commissioning and Routine Quality Assurance of the Vision RT AlignRT® System 157 Guang Li Chapter 9 ◾ Surface Guidance for Whole Breast and Partial Breast: Technical Aspects 187 Laura Padilla Chapter 10 ◾ Surface Guidance for Breast: Deep Inspiration Breath Hold 209 Xiaoli Tang Chapter 11 ◾ Breast Cancer Outcomes and Toxicity Reduction with SGRT 227 Orit Kaidar-Person, Icro Meattini, Marianne C. Aznar, and Philip Poortmans Chapter 12 ◾ Surface Guidance for Stereotactic Radiosurgery and Radiotherapy: Technical Aspects 239 Laura Cerviño and Grace Gwe-Ya Kim Chapter 13 ◾ Clinical Outcomes of Intracranial Surface-Guided Stereotactic Radiosurgery 255 Douglas a. rahn iii Chapter 14 ◾ Risk Analysis for SGRT-Based SRS/SRT 269 Ryan Manger Chapter 15 ◾ SBRT and Respiratory Motion Management Strategies with Surface Guidance 279 Michael J. Tallhamer Chapter 16 ◾ The Use of SGRT for SBRT without Respiratory Gating 303 Ryan Foster and John Heinzerling Chapter 17 ◾ Head and Neck 319 Bo Zhao Chapter 18 ◾ Surface Image Guidance for Treatment of Extremities 339 David p. Gierga Chapter 19 ◾ Application of SGRT in Pediatric Patients: The CHLA Experience 351 Arthur J. Olch, Alisha Chlebik, and Kenneth Wong Chapter 20 ◾ Skin Mark-Less Patient Setup: A Physicist’s Perspective 367 Vanessa Panettieri, Sandra Paul, and Catherine Russell Chapter 21 ◾ Tattoo/Skin Mark-Less Setups Using SGRT: A Radiation Therapist’s Perspective 391 Jacqueline Dorney Chapter 22 ◾ Introducing SGRT into the Clinic: A Radiation Therapist’s Perspective 399 Ellen Herron and Daniel Bailey Chapter 23 ◾ SGRT for Proton Therapy 421 Adam B. Paxton Chapter 24 ◾ Integration of Surface Imaging with Tomographic and Bore-Type Gantry Treatment Systems 437 Lu

Read more less

Book SynopsisThis volume in the popular series, Drugs and the Pharmaceutical Sciences, begins with the history of cancer treatment, carcinogens, and molecular mechanisms involved in cancer pathogenesis. It incudes conventional and advanced cancer therapies ranging from oral and parenteral preparations to advanced fabricated systems such as nanoparticles, liposomes, antibodies, aptamers, poly(amidoamine) and photodynamic therapies. The preparation and mechanisms of molecular targeting of cancer are presented and the authors focus on a diverse audience including undergraduates and research students.Features Timely coverage of changes in process control technology for the phamaceutical industry, a dynamic area in terms of products and manufacturing processes Provides an update on the unique requirements of these industries and how they differ from others, for example the microelectronics or specialized chemicals industries Draws on the author's vast experience in the field of industrial hygiene and hazardous materials Presents a collection of unique situations in which industrial hygiene was implemented to resolve a variety of scenarios and did not interfere with quality issues Addresses current topics relating to industry evolution such as migration of therapies to higher potency, RiskMAP, new modalities in medicines and treatments, large molecule therapeutics and conjugates

Read more less

Book SynopsisThere has been an exponential increase in the volume and quality of published research relating to breast disease over the past decades. This book identifies the 50 key scientific articles in the field of breast disease and breast surgery and examines their importance and impact on current clinical care.Among thousands of articles, a small fraction are truly ''game changing''. Such studies form the foundations of breast surgery today, and the selection of papers within this book provide the 50 landmark papers every 21st-century breast surgeon needs to know. A commentary to each carefully selected paper explains why these papers are so important, thus providing every surgeon with the foundation stones of knowledge in this fast-moving area.A valuable reference not only to the established surgeon, but also to breast surgery residents and trainees, as well as to more experienced surgeons as they continue to learn new techniques and approaches and to improve their knowledge

Read more less

Book SynopsisThis fully updated volume explores recently improved avenues to study urothelial carcinomas.Table of ContentsPart I: Molecular Characterization 1. Scoring Systems for Immunohistochemistry in Urothelial Carcinoma Mark-Sebastian Bösherz, Iryna V. Samarska, and Nadine Therese Gaisa 2. A Panel-Based Method for the Reproduction of Distinct Molecular Subtype Classifications of Muscle-Invasive Urothelial Bladder Cancer Csilla Olah and Tibor Szarvas 3. Analysis of Mutational Signatures Using the mutSignatures R Library Damiano Fantini and Joshua J. Meeks 4. A Drug Repurposing Pipeline Based on Bladder Cancer Integrated Proteotranscriptomics Signatures Marika Mokou, Shaman Narayanasamy, Rafael Stroggilos, Irina-Afrodita Balaur, Antonia Vlahou, Harald Mischak, and Maria Frantzi 5. Characterization of Native COMPASS Complex in Urothelial Carcinoma Cells by Size Exclusion Chromatography Christoph Peter, Wolfgang A. Schulz, and Patcharawalai Whongsiri Part II: Urothelial Carcinogenesis 6. Reconstructing Phylogenetic Relationship in Bladder Cancer: A Methodological Overview Lancelot Seillier and Martin Peifer 7. Using Sister Chromatid Exchange Assay to Detect Homologous Recombination Deficiency in Epigenetically Deregulated Urothelial Carcinoma Cells Theodoros Rampias and Apostolos Klinakis 8. Identification of STAG2 Mutant Bladder Cancers by Immunohistochemistry Youngrok Park, Alana Lelo, Brent Harris, Deborah L. Berry, Krysta Chaldekas, Jung-Sik Kim, and Todd Waldman Part III: Cellular and Animal Models 9. Genome-Wide CRISPR Screening for the Identification of Therapy-Resistance-Associated Genes in Urothelial Carcinoma Klaus Mantwill and Roman Nawroth 10. Tissue Slice Culture and Analysis of Tumor-Associated Hyaluronan in Urothelial Carcinoma William Donelan, Paul L. Crispen, and Sergei Kusmartsev Part IV: Biomarkers 11. NGS-Based Tumor-Informed Analysis of Circulating Tumor DNA Iver Nordentoft, Karin Birkenkamp-Demtröder, and Lars Dyrskjøt 12. Considering the Effects of Modern Point-of-Care Urine Biomarker Assays in Follow-Up of Patients with High-Risk Non-Muscle Invasive Bladder Cancer Thorsten H. Ecke, Natalya Benderska-Söder, Ekkehardt Bismarck, Bas W.G. van Rhijn, Tilman Todenhöfer, and Bernd J. Schmitz-Dräger 13. Simplex Droplet Digital PCR Assays for the Detection of TERT Promoter Mutations in Urine Samples for the Non-Invasive Diagnosis of Urothelial Cancer Maria Zvereva, Md Ismail Hosen, Nathalie Forey, Mahdi Sheikh, Caroline Kannengiesser, Ibrahima Ba, Arnaud Manel, Emmanuel Vian, and Florence Le Calvez-Kelm 14. Predictive Biomarkers of Response to Neoadjuvant Therapy in Muscle Invasive Bladder Cancer Jussi Nikkola and Peter Black 15. Assessment of PD-L1 Status in Urothelial Cancer Veronika Bahlinger, Arndt Hartmann, and Markus Eckstein Part V: Therapy Development 16. Epigenetic Priming and Development of New Combination Therapy Approaches Sarah Meneceur, Camilla M. Grunewald, Günter Niegisch, and Michèle. J. Hoffmann 17. Evaluation of FGFR Alteration Status in Urothelial Tumors Veronika Bahlinger, Markus Eckstein, Arndt Hartmann, and Robert Stöhr 18. Antibody-Drug-Conjugates (ADC): A Novel Treatment Option in Urothelial Carcinoma Günter Niegisch 19. Intravesical Infusion of Oncolytic Virus CG0070 in the Treatment of Bladder Cancer Paola Grandi, Andrea Darilek, Anay Moscu, Anu Pradhan, and Roger Li 20. Analysis of ICAM-1 Expression on Bladder Carcinoma Cell Lines and Infectivity and Oncolysis by Coxsackie Virus A21 Kate Relph, Mehreen Arif, Hardev Pandha, Nicola Annels, and Guy R. Simpson

Read more less

Book SynopsisThe Role of the Clinical Nurse Specialist in Cancer Care Gain a fresh and insightful perspective on the evolving role of the Clinical Nurse Specialist in the delivery of cancer services. The Role of the Clinical Nurse Specialist in Cancer Care explores the dynamic and essential world of the Clinical Nurse Specialist (CNS) in cancer care, covering both foundational and advanced topics and rooted in robust research and evidence-based practice. Trace the historical development of the CNS role while gaining invaluable patient and carer perspectives that provide essential guidance for professionals in this fieldExamine key aspects such as symptom management and non-medical prescribing, gaining a deeper understanding of the multifaceted responsibilities of Clinical Nurse SpecialistsFind vital subjects like leadership and multidisciplinary teamwork supplemented with practical tools to excel in your roleExplore comprehensive coverage of specialised areas within clinical nursing, including the unique challenges of caring for young adults with cancer, navigating the complexities of COVID-19, and utilising digital tools for enhanced patient care Whether you are a registered nurse aspiring to become a clinical nurse specialist or an established CNS seeking professional growth, The Role of the Clinical Nurse Specialist in Cancer Care provides invaluable insights and development opportunities. This engaging resource is also an excellent companion for advanced practitioners specialising in cancer care, ensuring they stay up-to-date with the latest advancements in this vital field.Table of ContentsList of Contributors xiv Foreword xvi Introduction xviii About the Companion Website xxi 1 Evolvement of Advanced Nursing Practice 1 Helen Kerr 1.1 Introduction 1 1.2 Evolvement of Nursing as a Profession 1 1.3 Advanced Nursing Practice 3 1.3.1 Criteria Associated with Advanced Nursing Practice 4 1.3.2 Advanced Practice Nurse Roles 6 1.3.3 Regulation 8 1.3.4 Components of Advanced Practice Nurse Roles 8 1.3.5 Education Requirements 8 1.3.6 Outcomes Associated with Advanced Practice Nurse Roles 9 1.3.7 Barriers to Advanced Practice Nursing Roles 9 1.3.8 Recommendations for Advanced Practice Nurse Roles 10 1.4 Conclusion 10 References 11 2 Emergence and Evolvement of the Clinical Nurse Specialist Role in Cancer Care 15 Helen Kerr 2.1 Introduction 15 2.2 Advanced Nursing Practice 15 2.3 Historical Context 16 2.4 Specialists vs. Generalists 17 2.5 Definition of a CNS 18 2.5.1 Role Blurring 18 2.6 Components of the Clinical Nurse Specialist Role 19 2.6.1 Direct Patient Care 20 2.6.2 Indirect Care 20 2.7 Professional Standards 21 2.8 Education Requirements 22 2.8.1 Impact of a Master’s Qualification 22 2.9 Outcomes of the Clinical Nurse Specialist Role 23 2.9.1 Outcomes Associated with the Clinical Nurse Specialist in Cancer Services 24 2.10 Specialist Practice in Cancer Care 25 2.11 Future Direction of the CNS 25 2.12 Conclusion 25 References 26 3 Patient Perspective 31 Johanna McMullan References 40 4 Carer’s Perspective 43 Trevor Wightman 5 Key Worker Role 49 Karen Armstrong and Helen Kerr 5.1 Introduction 49 5.2 The Key Worker 50 5.2.1 Provision of Information 52 5.2.2 Provision of Emotional and Supportive Care 52 5.2.3 Coordination of Services 53 5.3 Key Worker/Clinical Nurse Specialist Impact on Direct and Indirect Patient Care 54 5.4 Challenges in Practice 55 5.5 ‘First Impressions Count’ 57 5.6 Example of Change in Practice 58 5.7 Conclusion 59 References 59 6 Psychological Support 63 Caroline McCaughey, Edel Aughey, and Susan Smyth 6.1 Introduction 63 6.2 Part One: The Impact of a Cancer Diagnosis 64 6.2.1 Time Point One: Breaking Significant News 66 6.2.2 Time Point Two: Treatment Decision-Making 70 6.2.3 Time Point Three: Survivorship and Resilience 71 6.2.4 Fear of Recurrence 73 6.3 Part Two: Self-Care and the Clinical Nurse Specialist 74 6.4 Conclusion 77 References 78 7 Integrating Research and Evidence-Based Practice 84 Adrina O’Donnell, Ruth Boyd, and Clare McVeigh 7.1 Introduction 84 7.2 Evidence-Based Practice 85 7.3 Barriers to the Implementation of Evidence-Based Practice in the Clinical Setting 86 7.4 Role of Evidence-Based Practice in Caring for Patients with Cancer and Their Carers 87 7.5 Providing Evidence-Based Care as a Clinical Nurse Specialist 87 7.6 Clinical Application of Evidence-Based Practice by Clinical Nurse Specialists 88 7.7 Cancer Research and Clinical Trials 89 7.8 Cancer Clinical Trials, Research Nurses and the Role of the Clinical Nurse Specialist 91 7.9 The Role of the Clinical Nurse Specialist Along the Cancer Clinical Trial Patient Pathway 92 7.10 Conclusion 97 References 98 8 Symptom Management 104 Michelle Keenan and Helen Kerr 8.1 Introduction 104 8.2 Pain 105 8.2.1 Renal Impairment 107 8.2.2 Hepatic Impairment 108 8.2.3 Neuropathic Pain 109 8.3 Breathlessness 110 8.4 Nausea and Vomiting 112 8.5 Constipation 115 8.6 Conclusion 115 References 116 9 Multidisciplinary Teamworking 124 Hinal Patel and Oonagh McSorley 9.1 Introduction 124 9.2 The Multidisciplinary Team 125 9.2.1 Characteristics of an Effective Multidisciplinary Team 126 9.2.1.1 The Team 126 9.2.1.2 Multidisciplinary Meeting Organisational Logistics 128 9.2.1.3 Infrastructure for the Multidisciplinary Meeting 128 9.2.1.4 Person-Centred Clinical Decision-Making 128 9.2.1.5 Team Governance 129 9.3 The Role of the Clinical Nurse Specialist in Relation to the Multidisciplinary Team 129 9.3.1 Challenges of the Clinical Nurse Specialist Working in a Team 130 9.4 Conclusion 132 References 133 10 Leadership and the Clinical Nurse Specialist 136 Ruth Thompson and Monica Donovan 10.1 Introduction 136 10.2 Leadership 137 10.3 Self-Recognition of the Clinical Nurse Specialist as a Leader 137 10.4 Leadership in the Context of the Clinical Nurse Specialist 139 10.4.1 Clinical Leadership 140 10.4.1.1 Clinical Expertise and Coordination of Care 141 10.4.2 Professional Leadership 142 10.4.2.1 Enhancing Practice 143 10.4.2.2 Service Improvement and Innovation 143 10.4.2.3 Collaborative Working 144 10.5 Conclusion 144 References 144 11 Nurse-Led Clinics 149 Shelley Mooney and Helen Kerr 11.1 Introduction 149 11.2 Nurse-Led Care and the Launch of Nurse-Led Clinics in Healthcare 150 11.3 Components of a Nurse-Led Clinic 151 11.4 Introducing a Nurse-Led Clinic 152 11.5 Nursing Skills Required to Introduce and Establish a Nurse-Led Clinic 154 11.6 Approaches to Delivering a Nurse-Led Clinic 155 11.7 Patient Outcomes Related to Nurse-Led Clinics 156 11.8 Benefits of Nurse-Led Clinics for the Registered Nurse 157 11.9 Benefits of Nurse-Led Clinics for the Healthcare Organisation 157 11.10 Challenges to Implementing Nurse-Led Clinics 158 11.11 Nurse-Led Clinic Service Evaluation 159 11.12 Future of Nurse-Led Clinics 159 11.13 Reflection on the Role as a Uro-Oncology CNS Undertaking Nurse-Led Clinics 160 11.14 Conclusion 161 References 162 12 Non-Medical Prescribing 166 Laura Croan and Barry Quinn 12.1 Introduction 166 12.2 Background 167 12.3 Developments in Nursing Practice and the Role of Prescribing 168 12.3.1 Community Nurse Prescribing 168 12.3.2 Clinical Management Plans 169 12.3.3 Patient Group Directives 169 12.3.4 The Growth of Independent Prescribing 170 12.4 Preparing to Prescribe 172 12.5 Benefits and Challenges of Non-Medical Prescribing 172 12.6 Deciding to Become a Non-Medical Prescriber 173 12.7 Conclusion 177 References 178 13 Cancer in the Adolescent and Young Adult 181 Kerrie Sweeney and Helen Kerr 13.1 Introduction 181 13.2 Background to Adolescent and Young Adult Cancer Services 182 13.3 Person-Centred Adolescent and Young Adult Care 185 13.4 Support for Family and Significant Others 185 13.5 Holistic Care 186 13.6 Multidisciplinary Working 187 13.7 Healthcare Professional Knowledge 188 13.8 Adolescent and Young Adult Clinical Nurse Specialist Leadership Skills 189 13.9 Communication with Adolescents and Young Adults 189 13.10 Age-Appropriate Environments 191 13.11 Adolescent and Young Adult Peer Support 192 13.12 Adolescent and Young Adult Treatment Priorities 192 13.13 Transitional Adolescent and Young Adult Care 193 13.14 Living With and Beyond Cancer 194 13.15 Late Effects of Cancer Treatment 195 13.16 Palliative Adolescent and Young Adult Care 195 13.17 Co-production 196 13.18 Conclusion 196 References 197 14 COVID-19 and the Clinical Nurse Specialist 203 Stephanie Todd and Helen Kerr 14.1 Introduction 203 14.2 Impact on Healthcare Services and Frontline Healthcare Workers 204 14.3 Impact of COVID-19 on Cancer Services 205 14.4 The Role of the Clinical Nurse Specialist Prior to the COVID- 19 Pandemic 207 14.5 Devolvement of Staff over the COVID-19 Pandemic 208 14.6 Impact of COVID-19 on the Clinical Nurse Specialist Role and Patient Care 209 14.7 The Future of Healthcare Services Post–COVID-19 Pandemic 212 14.8 Conclusion 213 References 214 15 Digital Health 218 Amy Vercell and Sarah Hanbridge 15.1 Introduction 218 15.2 The Role of the Informatics Nurse/Chief Nursing Information Officer 220 15.3 Electronic Observations 220 15.4 Electronic Health Records 221 15.5 Digitalisation of Blood Glucose Monitoring 222 15.6 Electronic Nurse Prescribing 223 15.7 Nurse Digitally Requesting Bloods 224 15.8 Remote Consultations 224 15.9 Virtual Wards 225 15.10 Electronic Patient-Reported Outcome Measures 226 15.11 Mobile Cancer Applications 227 15.12 Home Blood Monitoring 228 15.13 Artificial Intelligence 229 15.14 Barriers to Digital Health 230 15.15 Conclusion 230 References 231 16 Future Direction of the Clinical Nurse Specialist in Cancer Care 236 Barry Quinn and Helen Kerr 16.1 Introduction 236 16.2 The Role of Caring and the Clinical Nurse Specialist 238 16.3 Developing Skills for Today and the Future 239 16.4 Leadership 240 16.5 Equality, Diversity and Inclusion in the Role of the Clinical Nurse Specialist 242 16.6 New Ways of Working 244 16.7 Self-Reflection 246 16.8 Conclusion 246 References 247 Index 250

Read more less

Book SynopsisFor those of us who have labored in the field of hormonal carcinogenesis, it has been most gratifying to see its rapid growth and increasing relevance in recent years. Although many factors and forces have contributed to this phenomenon, a few appear particularly significant. Perhaps foremost is the realization that two of the most prevalent cancers which afflict women and men; that is, breast and prostate, have essential hormonal component(s) to their etiologies. This should not surprise us since the high frequency of these cancers in human populations has to date not been attributed to any exogenous physical, environmental, or dietary factor(s). A similar argument may be applied to other less prevalent but equally important cancers including ovarian, endometrial, testicular, cervico vaginal, pituitary, thyroid, and sex hormone-associated hepatic neoplasms. The Office of ResearcTable of ContentsIntroductions.- Introductory Remarks.- Opening Address Important Questions in Women’s Health Research: Determining the Influence of Hormones on Health.- Symposium Presentations Mammary Carcinogenesis: A Unifying Hypothesis.- Regulation of Cytochrome P-450 and Carcinogenesis: Peroxisome Proliferator-Activated Receptor and Dioxin Receptor.- State Of The Art Lectures.- 1 Cell Cycle and Cell Proliferation.- 2 Role of a Cell Cycle Regulator in Hereditary and Sporadic Cancers.- 3 Molecular Cytogenetics of Solid Tumor Progression.- 4 Nucleocytoplasmic Shuttling of Estrogen Receptors Is Blocked by “Pure Antiestrogens”.- I. Epidemiology: Hormonal Cancers.- Causality in Hormone Associated Human Cancers.- 5 Breast Cancer Incidence in Women Exposed to Estrogen and Estrogen-Progestin Replacement Therapy.- 6 Breast Cancer Trends in Women in Sweden, the UK, and the USA in Relation to Their Past Use of Oral Contraceptives.- 7 Gene Expression in Familial Breast Cancer: A Genetic-Epidemiology Study of Premenopausal, Bilateral Breast Cancer.- 2. Breast/Mammary Gland.- The Importance of Human Breast Development in Mammary Carcinogenesis.- 8 Breast Susceptibility to Carcinogenesis.- 9 Hormones, Growth Factors and Gene Expression in Preneoplasias of the Mouse Mammary Gland.- 10 Pathogenesis of Ductal and Lobular Progestin-Induced Mammary Carcinomas in BALB/c Mice.- 3. Endometrium/Uterus.- 11 Is the hsp90 Connection Between Steroid Receptors and Immunosuppressant Binding Immunophilins Involved in the Control of Gene Transcription and Cell Growth?.- 12 Expression and Regulation of 17?-Hydroxysteroid Dehydrogenase Type 1 in Steroidogenic Cells and Estrogen Target Tissues.- Growth Factors in Endometrial Cancer.- 4. Kidney.- 13 Introduction Estrogens and Genitourinary Cancers of Syrian Hamsters.- 14 Interstitial Cell Origin of Estrogen-Induced Kidney Tumors in the Syrian Golden Hamster.- 15 Effects of Estrogens on Microtubule Assembly: Significance for Aneuploidy.- 16 Estrogen Carcinogenesis: A Sequential, Epi-Genotoxic, Multi-Stage Process.- 5. Liver.- Role of Estrogens in Liver Carcinogenesis.- 17 Hormonal Regulation of Hepatic Cell Proliferation and Apoptosis: Implications for Carcinogenesis.- 18 Mechanisms of Tamoxifen-Induced Genotoxicity and Carcinogenicity.- 19 Regulation of Growth-Associated Nuclear Transcription Factors During Growth Hormone-Regulated, Sex Differentiated Rat Liver Carcinogenesis.- 6. Prostate.- 20 Isolation of Differentially Expressed cDNAs from Prostate Cancer Cell Lines Using Differential Display PCR: Identification of an Androgen-Regulated Gene.- 21 Progression of LNCaP Human Prostate Carcinoma Cells: Androgen Receptor Activity and c-myc Gene.- 22 Regulation of Prostatic Growth and Gene Expression: Role of Stroma.- Concluding Remarks.- 23 Sex Hormones and Neoplastic Transformation.- CLINICAL FORUM: Risk and Benefits of Hormone Replacement Therapy and Oral Contraceptive Use.- Therapeutic Implications of Hormone Replacement Therapy and Oral Contraceptives.- 24 Postmenopausal Estrogen-Progestin Therapy in Relation to Cancers of the Endometrium and Breast.- 25 The Use of Hormone Replacement Therapy in Women Previously Treated for Breast Cancer.- 26 Cardioprotection by Hormone Replacement Therapy.- 27 Risk and Benefits of Oral Contraceptives.- 28 Oral Contraceptives and the Risk of Breast and Cervical Cancer.- Communications Session I. Epidemiology, Human Studies.- Some Aspects of Breast Cancer Epidemiology.- Risk of Breast Cancer Associated with Induced Abortion.- Family History of Breast Cancer as a Modifier of Other Risk Factors.- Oral Contraceptive Use and Reproductive Risk Factors for Breast Cancer: A Comparison of Results among Black and White Women.- Patterns of Cancer Mortality in Women Who Had Used Sex Steroid Hormones under Age 60.- Progestogen Use and Risk of Breast Cancer.- Five-Year Survival of Women with Breast Cancer According to Prior Use of Oral Contraceptives.- Plasma Prolactin and IGF-1 Levels in Young, Healthy, Nulliparous Women in Relation to Low Dose Oral Contraceptive Use.- Effect of a Low-Fat Diet on Estrogen and Bile Acid Metabolism in Normal Human Subjects.- Expression of GST? in Breast Cancer and its Relationship with the Expression of Estrogen Receptor and Progesterone Receptor.- p53 and Neu (c-erbB-2) Overexpression in Relation to Risk Factors for Breast Cancer.- Cost Effectiveness of Hormone Replacement Therapy in French Postmenopausal Women.- Tamoxifen Treatment Does Not Induce Endometrial Hyperplasia in Postmenopausal Women.- Uterine Myomas: A Model to Study Hormonal Regulation of Growth Related Genes.- Transforming Growth Factor ?1 Facilitates Cell Proliferation and Invasion in MAT-LyLu Prostatic Cancer Cells.- Quantitative Effects of Antiandrogen Therapy on High-Grade Prostatic Intraepithelial Neoplasia in Radical Prostatectomy Specimens.- Alterations in Circulating Levels of Androgens and PSA During Treatment with Finasteride in Men at High Risk for Prostate Cancer.- Session II. Cell & Molecular Biology, Metabolism.- Effect of Estradiol on MCF-7 Human Breast Cancer Cells: Ultrastructural Studies.- Estradiol and Tamoxifen Induce TGF-?l Gene Expression in Cultured Normal Human Breast Stromal Cells.- Estrogen and Anti-Estrogen Regulation of Amplified erbB2 Gene Expression in Human Breast Cancer Cells.- Evaluation of Conformational Changes in hER-HBD by Pharmacological Dissection of Hormone Dissociation Rates in a Homogeneous Hormone-Binding Assay.- Estradiol Promotion of Size and Number of Hepatic Enzyme-Altered Foci in Rats in the Absence of Cell Proliferation.- Expression of Liver-Enriched Transcription Factors During Progression in the Resistant-Hepatocyte Model.- Nuclear Protein Binding to the AP-1 and CRE Sites During Sex-Differentiated Promotion of Rat Liver Carcinogenesis.- Induction of Endometrial Cancer by Tamoxifen in the Rat.- Mechanisms of Anti-Estrogen and Retinoid Inhibition of Breast Cancer Cell Proliferation.- Bisphenol-A Disturbs Microtubule Assembly and Induces Micronuclei In Vitro.- Natural Estrogens Induce Modulation of Microtubules in Chinese Hamster V79 Cells in Culture.- Induction of Micronucleation, Spindle Disturbances, and Mitotic Arrest in Human Chorionic Villi Cells by 17?-Estradiol, Diethylstilbestrol, and Coumestrol.- Increased Nuclear IGF-I Receptor Level, Coupled with Attenuation in DNA Repair, Plays an Important Role in Estrogen-Induced Carcinogenesis.- Pattern of Reproductive Aging in Female Rats Can Affect Mammary Tumor Incidence.- Antiproliferative Activity of Luteolin, a Naturally-Occurring Edible Plant Flavone, Against Estrone-Induced Cell Proliferation in the Mammary Gland of Noble Rats.- Sex Hormone-Induced Prostatic Carcinogenesis in Noble Rats Involves Genetic Damage and Cell Proliferation.- Catechol Estrogen Analogs as Probes of Estrogen Carcinogenesis.- In-Vitro Metabolites of Coumestrol.

Read more less

Book SynopsisThis book presents in a comprehensive way cur the clinical care of the patient with head and neck rent advances in the management of neoplasia cancer involvement and/or its complications. and associated complications of the head and Today''s complex treatments in oncology re neck. A broad range of clinical considerations is quire a comprehensive approach to effect a posi discussed following overviews of relevant basic tive result for the cancer patient whose facial biologic issues and the roles of various disci appearance and function are compromised. We plines. Each chapter has been structured to trust that physicians, dentists, nurses, dental stand by itself; at the same time, obvious rela hygienists, and individuals in the supportive ser tionships with other chapters have been noted. vices involved in the management of the cancer We are pleased that this book represents, in ouTable of ContentsI. Introduction.- 1. Cancer, its complications, and the head and neck.- 2. Pathology of malignancy.- 3. Biology and biochemistry of metastatic cells.- II. Principles Of Management.- 4. Principles of surgical oncology.- 5. Principles of radiation therapy.- 6. Principles of chemotherapy.- 7. Principles of immunology.- 8. Principles of bone marrow transplantation.- 9. Principles of infection management.- III. Diagnosis And Management Of Head And Neck Neoplasia.- 10. Initial detection and evaluation: intraoral neoplasms.- 11. Initial detection and evaluation: extraoral neoplasms.- 12. Diagnostic radiology for head and neck neoplasms with emphasis on computerized tomography.- 13. Neoplasms of the salivary glands.- 14. Nonmucosal neoplasms of the maxillofacial region.- 15. Surgical management of head and neck neoplasia.- 16. Radiotherapeutic management of head and neck neoplasia.- 17. Chemotherapeutic management of head and neck neoplasia.- 18. Assessment of success of treatment of head and neck neoplasia.- IV. Head And Neck Complications Of Cancer Therapy.- 19. Oral complications associated with hematologic neoplasms and their treatment.- 20. Head and neck neurologic complications of malignancy.- 21. Head and neck complications of bone marrow transplantation.- 22. Oral complications of radiation therapy.- V. Supportive Care.- 23. Prosthetic management.- 24. Standards for nursing care of the oral cavity.- 25. Psychosocial effect of cancer on the patient and the family.- 26. Nutrition in the patient with compromised oral function.- Appendix: Staging of head and neck neoplasia.

Read more less

Book SynopsisThis new work on oral complications of cancer chemotherapy is edited by two dentists who have made pioneering contributions in this previously neglected area. Their efforts have established the invaluable role of the dentist in oncologic research and cancer patient management. The editors have collected nine chapters that will be of interest to dentists and dental hygienists, oncology nurses, and all physicians treating cancer patients with chemo therapeutic agents. Background chapters on oral complications of cancer chemotherapy, the pharmacology of chemotherapeutic agents, and principles of infection management and prevention set the stage for more specific chapters focusing on prevention and treatment of chemotherapy induced oral and dental disorders. Valuable contributions to the supportive care of the cancer patient are contained in this book. A full comprehension of this boTable of Contents1. Epidemiology, Frequency, Distribution, Mechanisms, and Histopathology.- 2. Pharmacology of Chemotherapeutic Agents.- 3. Principles of Infection Management and Prevention.- 4. Oral Microbial Changes and Infections during Cancer Chemotherapy.- 5. Bacterial Infections: Periodontal and Dental Disease.- 6. Oral Complications of Bone-Marrow Transplantation.- 7. Dental Management of Patients Receiving Chemotherapy.- 8. Guidelines for Oral Hygiene, Denture Care, and Nutrition in Patients with Oral Complications.- 9. Establishment of a Comprehensive Oral Oncology Program: Services, Facilities, and Management.

Read more less

Book SynopsisManagement of Soft Tissue Sarcoma addresses the diagnosis and best current management of adult soft tissue sarcomas. Both clinical and molecular diagnoses are addressed, and tumor histopathology is employed as the basis of treatment recommendations including surgery, radiation therapy, systemic therapy and novel therapeutics.Trade Review“This is an excellent monograph of the Diagnosis, Pathology, Imaging, Treatment, and Surgical outcomes of sarcomas and related tumors of the soft tissue variety. … This is a very good book for oropedic surgeons, patologists, students, and clinicians with an interest in the diagnosis and treatment of high and low grade liposarcomas, leomyosarcomas, benign type lesions, and other kind of subcutaneous tumors with distant lung, brain, and liver metastases.” (Joseph J. Grenier, Amazon.com, October, 2015)“This is an impressive book. Written by a surgeon, a pathologist and an oncologist, the book draws heavily on the Memorial Sloan-Kettering Cancer Center soft tissue sarcoma (STS) database. … it is a book that should be in the library of any sarcoma unit and will appeal to the sub-specialist in Orthopaedic Oncology.” (Robert U. Ashford, European Journal of Orthopaedic Surgery & Traumatology, Vol. 24, 2014)“The book is laid out in 27 chapters, with an impressive inclusion of a wide array of sarcoma histology. One of the real strengths of the book is the quality and number of images, figures, tables, and graphs. … The overall outline of the text is well done. … This book is a unique and important addition to the sarcoma literature. … this edtion should find itself on every medical oncologist’s bookshelf … .” (Larry C. Daugherty and Sanjay P. Bagaria, Journal of Radiation Oncology, Vol. 3, 2014)Table of ContentsPrefaceIntroduction 1. General Description2. Natural History – Importance of Size, Site, Histopathology3. General Statement as to Efficacy of Surgery / Chemotherapy / Radiation Therapy Part I. Management by Histopathology - Introduction4. Gastrointestinal Stromal Tumor (GIST)5. Liposarcoma 6. Leiomyosarcoma 7. Undifferentiated Pleomorphic Sarcoma (UPS) (Malignant Fibrous Histiocytoma - MFH) / Myxofibrosarcoma 8. Synovial Sarcoma 9. Malignant Peripheral Nerve Sheath Tumor (MPNST) / Triton Tumor10. Desmoid Tumor / Deep-Seated Fibromatosis (Desmoid-type Fibromatosis)11. Solitary Fibrous Tumor / Hemangiopericytoma12. Fibrosarcoma and its Variants13. Vascular Sarcomas14. Epithelioid Sarcoma15. Sarcomas more Common in Children 16. Radiation Induced Sarcoma17. Alveolar Soft Part Sarcoma 18. Clear Cell Sarcoma / Melanoma of Soft Parts 19. Desmoplastic Small Round Cell Tumor 20. Extraskeletal Myxoid Chondrosarcoma 21. Other Uterine Sarcomas22. Extraskeletal Osteogenic Sarcoma23. Sustentacular Tumors of Lymph Tissue24. Uncommon / Unique Sites Part II. Benign and Less Aggressive Lesions - Introduction25. Mostly Benign / Rarely Metastasizing26. Benign Tumors27. Reactive Lesions10. Desmoid Tumor / Deep-Seated Fibromatosis (Desmoid-type Fibromatosis)11. Solitary Fibrous Tumor / Hemangiopericytoma12. Fibrosarcoma and its Variants13. Vascular Sarcomas14. Epithelioid Sarcoma15. Sarcomas more Common in Children 16. Radiation Induced Sarcoma17. Alveolar Soft Part Sarcoma 18. Clear Cell Sarcoma / Melanoma of Soft Parts 19. Desmoplastic Small Round Cell Tumor 20. Extraskeletal Myxoid Chondrosarcoma 21. Other Uterine Sarcomas22. Extraskeletal Osteogenic Sarcoma23. Sustentacular Tumors of Lymph Tissue24. Uncommon / Unique Sites Part II. Benign and Less Aggressive Lesions - Introduction25. Mostly Benign / Rarely Metastasizing26. Benign Tumors27. Reactive Lesions2. Natural History – Importance of Size, Site, Histopathology3. General Statement as to Efficacy of Surgery / Chemotherapy / Radiation Therapy Part I. Management by Histopathology - Introduction4. Gastrointestinal Stromal Tumor (GIST)5. Liposarcoma 6. Leiomyosarcoma 7. Undifferentiated Pleomorphic Sarcoma (UPS) (Malignant Fibrous Histiocytoma - MFH) / Myxofibrosarcoma 8. Synovial Sarcoma 9. Malignant Peripheral Nerve Sheath Tumor (MPNST) / Triton Tumor10. Desmoid Tumor / Deep-Seated Fibromatosis (Desmoid-type Fibromatosis)11. Solitary Fibrous Tumor / Hemangiopericytoma12. Fibrosarcoma and its Variants13. Vascular Sarcomas14. Epithelioid Sarcoma15. Sarcomas more Common in Children 16. Radiation Induced Sarcoma17. Alveolar Soft Part Sarcoma 18. Clear Cell Sarcoma / Melanoma of Soft Parts 19. Desmoplastic Small Round Cell Tumor 20. Extraskeletal Myxoid Chondrosarcoma 21. Other Uterine Sarcomas22. Extraskeletal Osteogenic Sarcoma23. Sustentacular Tumors of Lymph Tissue24. Uncommon / Unique Sites Part II. Benign and Less Aggressive Lesions - Introduction25. Mostly Benign / Rarely Metastasizing26. Benign Tumors27. Reactive Lesions10. Desmoid Tumor / Deep-Seated Fibromatosis (Desmoid-type Fibromatosis)11. Solitary Fibrous Tumor / Hemangiopericytoma12. Fibrosarcoma and its Variants13. Vascular Sarcomas14. Epithelioid Sarcoma15. Sarcomas more Common in Children 16. Radiation Induced Sarcoma17. Alveolar Soft Part Sarcoma 18. Clear Cell Sarcoma / Melanoma of Soft Parts 19. Desmoplastic Small Round Cell Tumor 20. Extraskeletal Myxoid Chondrosarcoma 21. Other Uterine Sarcomas22. Extraskeletal Osteogenic Sarcoma23. Sustentacular Tumors of Lymph Tissue24. Uncommon / Unique Sites Part II. Benign and Less Aggressive Lesions - Introduction25. Mostly Benign / Rarely Metastasizing26. Benign Tumors27. Reactive Lesions

Read more less

Book Synopsis1. Human Papillomaviruses and Cancer: A Retrospective.- 2. Regulation of E6 and E7 Oncogene Transcription.- 3. E6 Protein.- 4. E7 Protein.- 5. Immunological Aspects of the E6 and E7 Oncogenes: Tools for Diagnosis and Therapeutic Intervention.Table of Contents1. Human Papillomaviruses and Cancer: A Retrospective.- 2. Regulation of E6 and E7 Oncogene Transcription.- 3. E6 Protein.- 4. E7 Protein.- 5. Immunological Aspects of the E6 and E7 Oncogenes: Tools for Diagnosis and Therapeutic Intervention.

Read more less

Book SynopsisPart of the popular Biopsy Interpretation Series, Biopsy Interpretation of the Skin: Primary Non-Lymphoid Cutaneous Neoplasia, Second Edition , is a concise, practical resource with a strong focus on diagnosis. It offers guidelines on how and when to biopsy the skin and provides superb coverage of common and uncommon non-lymphoid neoplasms of the skin. Focusing on the daily tasks and needs of the general pathologist, this updated Second Edition is an excellent bench reference and education resource for the interpretation of the most common skin biopsies. Incorporates recent advances in the biology of skin cancer which have led to important biologic therapies for melanoma, basal cell carcinoma, and squamous cell carcinoma. Includes new chapters on the clinical approach to surgical conditions of the skin and soft tissue tumors. Offers online access to 375 additional figures, plus an online multiple-choice test bank that is ideal for board exam preparat

Read more less

Book SynopsisThis unique synthesis of chapters from top experts in their fields, targets the very important and upcoming area of cancer biomarkers and the need for better and more rigorous design and clinical trial. The book covers several aspects of cancer molecular markers from innovation, screening, controversies and future directions. The primary target audience for the book includes PhD and MD students, researchers, biologists, medical doctors and professionals who are interested in mechanistic studies on cancer diagnosis and translational benefits from personalized cancer treatment using the new era of biomarkers.Table of ContentsImproving Research on Biomarkers for Early Detection and Screening of Cancers. Biomarkers of Oxidative Stress in Carcinogenesis. ß-Catenin: a Novel Biomarker and Therapeutic Target in Liver Cancer. Urine Biomarkers for Prostate Cancer Detection. Ectodomain Shedding as a Mechanism to Generate Cancer Biomarkers (Ectomarkers). The BRCT Signaling ‘landscape’: Emerging Concepts and Implications in Tumorigenesis and Cancer Diagnostics. Cellular Senescence and Cancer Development: Antagonistic and Synergistic Relations. Micro-RNAs: From Regulators of Gene Expression to Cancer Biomarkers. Targeting PARP-1 in Breast Cancer: The Paradigm of a DNA Repair-based Therapeutic Strategy. Statins in Prostate Cancer: Prevention and Treatment. Mechanistic Aspects of Oxidative Stress Involvement in Human Environmental and Occupational Carcinogenesis.

Read more less

Book SynopsisPrinciples of Clinical Cancer Research provides comprehensive coverage of the fundamentals of clinical cancer research, including the full spectrum of methodologies used in the field. For those involved in research or considering research careers, this book offers a mix of practical advice and analytical tools for effective training in theoretical principles as well as specific, usable teaching examples. The clinical oncologist or trainee will find a high-yield, practical guide to the interpretation of the oncology literature and the application of data to real-world settings. Valuable for both researchers and clinicians who wish to sharpen their skills, this book contains all of the cornerstones and explanations needed to produce and recognize quality clinical science in oncology.Written from the physician-scientist's perspective, the book lays a strong foundation in preclinical sciences that is highly relevant to careers in translational oncology research along with coverage of population and outcomes research and clinical trials. It brings together fundamental principles in oncology with the statistical concepts one needs to know to design and interpret studies successfully. With each chapter including perspectives of both clinicians and scientists or biostatisticians, Principles of Clinical Cancer Research provides balanced, instructive, and high-quality topic overviews and applications that are accessible and thorough for anyone in the field.KEY FEATURES: Gives real-world examples and rationales behind which research methods to use when and why Includes numerous tables featuring key statistical methods and programming commands used in everyday clinical research Contains illustrative practical examples and figures in each chapter to help the reader master concepts Provides tips and pointers for structuring a career, avoiding pitfalls, and achieving success in the field of clinical cancer research Access to fully downloadable eBook

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book SynopsisCaring for an individual receiving radiation therapy as part of overall cancer care requires a patient-focused approach. To support this patient population, nurses across treatment settings must constantly expand and refine their knowledge of advancements in radiation therapy technology, research, and evidence-based practice.In this fifth edition of the Oncology Nursing Society Manual for Radiation Oncology Nursing Practice and Education, nurses of all experience levels will advance their knowledge of radiation biology and protection, diverse radiation therapy modalities, combination treatments, site- and disease-specific issues, symptom management, special populations, and much more.This expanded and revised resource includes significant updates and additions to best reflect advancements in radiation oncology. New topics address patients with cognitive changes and dementia, general distress and coping, special populations including individuals with mental illness, special needs related to late effects of treatment and cardiac toxicities, and the latest treatment modalities. This manual will serve oncology nurses, advanced practice clinicians, educators, and administrators seeking the education and skills required to care for patients receiving radiation therapy and their families.

Read more less

Book SynopsisCan you overcome lung cancer without harsh chemicals, surgery and debilitation? Are alternative interventions effective? Why do conventional physicians not use them? Can you prevent cancer recurrences and live into old age without chronic diseases and prescribed medications? This book answers these and other questions. This is one of the most comprehensive books available on alternative treatments for lung cancer. It explains the treatments used successfully by a health professional/cancer survivor of 36 years and by some of the leading medical and health practitioners currently in the field. G. Edward Griffin, Author of World Without Cancer, The Politics of Cancer Therapy, and other books and films. Recipient of the Telly Award for Excellence in Television Production. President of American Media.Trade ReviewThis is one of the most comprehensive books available on alternative treatments for lung cancer. It explains the treatments used successfully by a health professional/cancer survivor of 36 years and by some of the leading medical and health practitioners currently in the field. It will be useful, not just for the lay reader, but also for therapists and others with a scientific background. --G. Edward Griffin, Author of World Without Cancer, The Politics of Cancer Therapy, and other books and films. Recipient of the Telly Award for Excellence in Television Production. President of American Media. If you are ever diagnosed with advanced cancer, the odds are very good that your oncologist will tell you that unless you immediately consent to chemotherapy you are going to die. This is a lie! I know, I have been treating conventional chemotherapy failures for years. Other than for leukemia or lymphoma, conventional chemotherapy is almost always a death sentence. There are so many more effective ways to treat advanced cancer, and Dr. Carl Helvie's book, You Can Beat Lung Cancer: Using Alternative/Integrative Interventions, describes some of the most effective. In addition, his book is packed with references and information sources that will help anyone fighting cancer learn more about how to go about it successfully. --Frank Shallenberger, MD, HMD, ABAAM, Medical Director, The Nevada Center of Alternative Medicine, Editor: Real Cures Newsletter and Author This is a valuable piece of writing, to give people hope that there are other ways back to health from cancer, than the 'slash, burn and poison' offered by conventional oncology. --Robert A. Eslinger, D.O., H.M.D. | Medical Director, Reno Integrative Medical Center

Read more less

Designed for quick, everyday reference, Handbook of Targeted Cancer Therapy and Immunotherapy: Gastrointestinal Cancer provides a practical overview of this rapidly advancing field. Comprehensive yet concise, this easy-access resource by Dr. Milind Javle of MD Anderson Cancer Center and Dr. Mitesh J. Board of Mayo Clinic helps you filter and apply the most recent discoveries as they pertain to specific tumor types, actionable molecular targets, and clinical performance of investigational targeted agents and combinations of agents. Covers gastrointestinal cancer targets—stage 1, 2, and 3 trials and preliminary results, as well as approved therapies. Includes sections on Sequencing Technologies, and Targeted and Immunotherapy Agents. Organizes information by tumor type, pathway, and drug name, so you can approach clinical challenges from any direction. Highlights FDA approvals throughout. Pocket-sized and color coded to help you find information quickly and easily. , Enrich Your eBook Reading Experience Read directly on your preferred device(s), such as computer, tablet, or smartphone. Easily convert to audiobook, powering your content with natural language text-to-speech. ,

Read more less

Book Synopsis

Read more less

Book SynopsisThis groundbreaking book presents a unique and practical approach to the evolving field of exercise oncology - the study of physical activity in the context of cancer prevention and control. Presenting the current state of the art, the book is sensibly divided into four thematic sections. Following an opening chapter presenting an overview and timeline of exercise oncology, the chapters comprising part I discuss primary cancer prevention, physical activity and survivorship, and the mechanisms by which these operate. Diagnosis and treatment considerations are discussed in part II, including prehabilitation, exercise during surgical recovery, infusion and radiation therapies, and treatment efficacy. Post-treatment and end-of-life care are covered in part III, including cardio-oncology, energetics and palliative care. Part IV presents behavioral, logistical and policy-making considerations, highlighting a multidisciplinary approach to exercise oncology as well as practical matters such as reimbursement and economics.Written and edited by experts in the field, Exercise Oncology will be a go-to practical resource for sports medicine clinicians, family and primary care physicians, oncologists, physical therapy and rehabilitation specialists, and all medical professionals who treat cancer patients.Table of ContentsChapter 1. Exercise Oncology: Past and Present Kathryn H. SchmitzPart 1 - Physical Activity and Cancer Prevention Chapter 2. Primary PreventionErika Rees-Punia, Alpa V. Patel Chapter 3. Physical Activity and Cancer SurvivalChristine M. Friedenreich, Chelsea R. Stone, Sandra C. Hayes Chapter 4. Mechanisms of Exercise in Cancer Prevention, Treatment and SurvivorshipHannah Savage, Keri L. Schadler Part 2 - From Diagnosis through TreatmentChapter 5. Exercise Oncology from Diagnosis through Treatment: An Overview of Outcomes and ConsiderationsCiaran M. Fairman, Daniel A. GalvãoChapter 6. Prehabilitation: An Emerging Standard in Exercise OncologyNicole L. Stout, Julie K Silver, Jennifer Baima, Sasha E. Knowlton, Xiaorong HuChapter 7. Exercise during Surgical Recovery Rosa M. Pasculli, Jonas Sokolof, Elizabeth Olecki, Kelly Stahl, Niraj GusaniChapter 8. Exercise during Infusion TherapyKristin L. Campbell, Amy KirkhamChapter 9. Exercise During Radiation TherapyJoachim WiskemannChapter 10. Effects of Exercise on Cancer Treatment Completion and EfficacyAndria R. Morielli, Kerry S. Courneya Part 3 – Post-treatment to End of LifeChapter 11. Exercise Oncology from Post-Treatment to End of Life: An Overview of Outcomes and ConsiderationsKira Bloomquist, Sandra C. Hayes Chapter 12. Exercise during Immediate Post-treatment Kerri Winters-Stone, Mary Medysky, Anna L. SchwartzChapter 13. Long-term and Late Effects of Cancer Treatments on Prescribing Physical ActivityAnna L. Schwartz, Jennifer W. Bea, Kerri Winters-StoneChapter 14. Exercise and Cardio-OncologyAmy M. Berkman, Susan C. Gilchrist Chapter 15. Energetics and Cancer OutcomesLeah M. Ferrucci, Melinda L. IrwinChapter 16. Exercise for Advanced Cancers, Metastatic Disease and Palliative CareSonya Lowe, Christopher Sellar, Kirsten Suderman, Margaret L. McNeely Part 4 - Behavior, logistics, and policyChapter 17. Cancer Survivors Becoming and Staying Physically Active: Challenges of Behavior ChangeBernardine M. Pinto, Madison M. Kindred, Chloe GrimmettChapter 18. Making Exercise Standard in Cancer Care Karen Basen-Engquist, Nathan H. ParkerChapter 19. Viewing Exercise Oncology through the Lens of MultidisciplinarityMartijn M. StuiverChapter 20. Policy and Reimbursement Considerations for Exercise Programming in CancerAndrea Cheville, Jennifer Baima, Philip Chang, Charles Mitchell, Stephanie Otto, Sonal Oza, David S. ZuckerChapter 21. Shaping the Future of Exercise OncologyKathryn H. Schmitz

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Book SynopsisThis book is a concise practical guide designed to facilitate the clinical decision-making process in the management of pediatric skin cancers. Dermatologists, oncologists and general pediatricians who offer primary care to children must be knowledgeable in identifying and managing dermatological cancers, and this title provides insightful reviews of a number of common and rare dermatologic cases. Clinical cases are a key component in modern medical education, assisting the trainee or recertifying clinician to work through unusual scenarios using best practice techniques. Pediatric dermatology is a particularly important discipline in this regard since it is a highly visual subject requiring the reader to describe often very subtle differences in the presentation of patients and define accurately the diagnostic and management criteria on which to base their clinical decision-making. Clinical Cases in Pediatric Skin Cancers concisely covers how to approach diagnosing and managing skin cancers in pediatric patients. Each chapter focuses on a particular case and emphasizes how to make an appropriate choice when deciding which diagnostic tool or management strategy would be most suitable. Potential complications are detailed and management tips provided to enable the reader to develop a deep understanding of how approach the care of these patients within their day-to-day clinical practice. This book therefore represents an ideal up-to-date resource for all practitioners who encounter these cases as part of their everyday practice.Table of Contents20-30 cases/chapters of 4-6 pages (=c. 2500 words) that cover the discipline in a structured fashion and covering all aspects of the topicChapters will include the following:Conventional melanoma Spitzoid melanomaCongenital melanocytic nevus MelanomaBasal Cell CarcinomasSquamous Cell Carcinomas Benign skin neoplasmsGenetic skin neoplasmsVirus induced skin neoplasms in children

Read more less

Book SynopsisCancer screening is a prominent strategy in cancer control in the United States, yet the ability to correctly interpret cancer screening data eludes many researchers, clinicians, and policy makers. This open access primer rectifies that situation by teaching readers, in simple language and with straightforward examples, why and how the population-level cancer burden changes when screening is implemented, and how we assess whether that change is of benefit. This book provides an in-depth look at the many aspects of cancer screening and its assessment, including screening phenomena, performance measures, population-level outcomes, research designs, and other important and timely topics. Concise, accessible, and focused, Assessment of Cancer Screening: A Primer is best suited to those with education or experience in clinical research or public health in the United States - no previous knowledge of cancer screening assessment is necessary. This is the first text dedicated to cancer screening theory and methodology to be published in 20 years.Table of ContentsFoundations.- Behind the scenes.- Performance measures.- Population measures: definitions.- Population measures: cancer screening’s impact.- Experimental research designs.- Observational research designs.- Cancer prevention screening.- Additional considerations.- Closing thoughts

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Book SynopsisThis book provides a thorough background to the emerging field of medical robotics. It covers the mathematics needed to understand the use of robotic devices in medicine, including but not limited to robot kinematics, hand-eye and robot-world calibration, reconstruction, registration, motion planning, motion prediction, motion correlation, motion replication and motion learning. Additionally, basic methods behind state-of-the art robots like the DaVinci system, the CyberKnife, motorized C-arms and operating microscopes as well as stereotactic frames are presented. The book is a text book for undergraduates in computer science and engineering.The main idea of the book is to motivate the methods in robotics in medical applications rather than industrial applications. The book then follows the standard path for a robotics textbook. It is thus suitable for a first course in robotics for undergraduates. It is the first textbook on medical robotics.Table of ContentsIntroduction.- Describing Spatial Position and Orientation.- Robot Kinematics.- Joint Velocities and Jacobi-Matrices.- Navigation and Registration.- Treatment Planning.- Motion Correlation and Tracking.- Motion Prediction.- Motion Replication.- Applications of Surgical Robotics.- Rehabilitation, Neuroprosthetics and Brain-Machine Interfaces.

Read more less

Book SynopsisSquamous cell cancers of the head and neck (SCCHN), also known as head and neck cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and pharynx, and are diagnosed in over 500,000 patients worldwide each year, accounting for 5% of all malignancies. It is estimated that approximately 50,000 patients develop head and neck cancer annually in the United States, of whom approximately 50% succumb to this cancer. For most cases of SCCHN, treatment is multimodal, often combining surgery or irradiation with chemotherapy; even successfully treated patients frequently experience durable and severe side effects. Improving cure rates and reducing chronic morbidity are urgent clinical needs for head and neck cancer. However, in contrast to cancer types such as breast or prostate that have been much studied and have well-defined biology, until recently, relatively few researchers investigated the molecular basis of HNC, making it difficult to design targeted treatments with better efficacy and less debilitating side effects. This volume will provide an overview of the factors contributing to disease pathogenesis, including the recognition of discrete molecular subtypes with distinct etiology, prognosis, and treatment response. This volume will familiarize the reader with the critical signaling pathways and oncogenic drivers for HNC. It will outline the differences between HPV-positive and HPV-negative disease, and how these differences affect treatment choice and outcome. The book will emphasize developments in the past five years, including the growing understanding of the genomic and epigenomic features of the disease based on analysis of next generation sequencing (NGS) data, and timely topics such as the analysis of HNC stem cell populations, non-coding mRNAs, and inflammatory response. It will address exciting new therapeutic approaches such as the use of immunotherapies to treat HNC patients. Overall, the book will provide the reader with current understanding of the biology and treatment of the disease, and describe timely questions that will guide future research aimed at controlling and curing this disease.Trade Review“The book is intended primarily for clinicians, fellows, interns, and trainees, but medical students who may be interested in head and neck cancer but face the challenge of updating themselves on the latest innovations may also find this book very useful. … this is an informative and authoritative book on the subject that includes experiences from clinicians and scientists working on head and neck cancer at some of the most renowned cancer centers in the world.” (Ravi Salgia, Doody's Book Reviews, March, 2019)Table of ContentsChapter 1: Overview: B. Burtness and E. GolemisChapter 2: HER inhibition in HNC: E. Golemis and B. BurtnessChapter 3: MET: T Beck, Fox Chase Cancer CenterChapter 4: PI3K/mTOR/AMPK: C. Chung, Moffit Cancer CenterChapter 5: Jak/STAT: J.R. Grandis, UCSFChapter 6: TGFb: Neiman and Wang, University of ColoradoChapter 7: Wnt and catenin Signaling: MA Kukurusinska, Boston UniversityChapter 8: P53/p63/p73: B. BurtnessChapter 9: DNA damage: R. Bindra, Yale UniversityChapter 10: APOBEC Proteins: K.S. Anderson, Yale UniversityChapter 11: Hypoxia, including HIF1: Q. Le, Stanford UniversityChapter 12: VEGF/Angiogenesis and Antiangiogenic Therapy: A Argiris, Thomas Jefferson UniversityChapter 13: Sequencing/genomic insights: J.Myers, MD AndersonChapter 14: Gene expression, Methylation, and histones: R.Mehra, A.Andrews, S.Peri, Fox Chase Cancer Center and A.Bhatia, Yale UniversityChapter 15: Inflammation: Carter Van Waes, NIHChapter 16:Immunotherapy: Ferris and Baumann, UPMCChapter 17: FAK/Integrin pathway inhibitors: Nils Cordes, DresdenChapter 18: Targeting cell cycle controls: E.GolemisChapter 19: Head and neck cancer stem cells: L.Bourguignon, UCSFChapter 20: Non-coding RNAs: C.Punyadeera, Queensland UniversityChapter 21: Epidemiology of HPV: Ragin and Lui, Fox Chase Cancer CenterChapter 22: DNA damage in HPV-positive SCCHN: WG Yarbrough, Yale UniversityChapter 23: Treatment paradigms in HPV-positive SCCHN: A Cmelak, Vanderbilt University

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Book SynopsisThis richly illustrated book provides a comprehensive survey of the growing role of medical imaging studies in the detection, staging, grading, tissue characterization, and post-treatment follow-up of soft tissue tumors. For each tumor group, imaging findings are correlated with clinical, epidemiologic, and histologic data. The relative merits and indications of various imaging modalities are discussed and compared. Particular emphasis is placed on MRI because of its unique contrast resolution and multiplanar imaging capabilities. This third, revised and updated edition includes new chapters on genetics and molecular biology and on pathology of soft tissue tumors, with respect to the new World Health Organization (WHO) classification of soft tissue tumors. It aims to serve both as a systematic, descriptive textbook and as a rich pictorial database of soft tissue masses. The addition of numerous new illustrations of common and rare soft tissue tumors will further increase the scientific and educational value of this third edition.Trade ReviewFrom the reviews of the third edition: RAD-Magazine, Nov. 2006: "There is a lot of knowledge and experience between the two book covers, which is well presented...." "This third edition of ‘Imaging of soft tissue tumors’ has been considerably enlarged by using the bank data of the Belgian Soft Tissue Neoplasm Registry. … This new edition should be recommended to radiologists and nuclear medicine doctors, surgeons, oncologists, graduated or in training, but it is also of interest for the specialists related to the different soft tissues." (F Duparc, Surgical and Radiologic Anatomy, Vol. 28, 2006)Table of ContentsDiagnostic Modalities.- Ultrasound of Soft Tissue Tumors.- Color Doppler Ultrasound.- Plain Radiography, Angiography, and Computed Tomography.- Nuclear Medicine Imaging.- Magnetic Resonance Imaging.- Dynamic Contrast-Enhanced Magnetic Resonance Imaging.- Cytogenetics and Molecular Genetics of Soft Tissue Tumors and Bone Tumors.- Soft Tissue Tumours: the Surgical Pathologist’s Perspective.- Biopsy of Soft Tissue Tumors.- Staging, Grading, and Tissue Specific Diagnosis.- Staging.- Grading and Tissue-Specific Diagnosis.- General Imaging Strategy of Soft Tissue Tumors.- Imaging of Soft Tissue Tumors.- Tumors of Connective Tissue.- Fibrohistiocytic Tumors.- Lipomatous Tumors.- Tumors and Tumor-like Lesions of Blood Vessels.- Lymphatic Tumors.- Tumors of Muscular Origin.- Synovial Tumors.- Tumors of Peripheral Nerves.- Extraskeletal Cartilaginous and Osseous Tumors.- Primitive Neuroectodermal Tumors and Related Lesions.- Lesions of Uncertain Differentiation.- Pseudotumoral Lesions.- Soft Tissue Metastasis.- Soft Tissue Lymphoma.- Imaging of Soft Tissue Tumors in The Pediatric Patient.- Imaging After Treatment.- Follow-Up Imaging of Soft Tissue Tumors.

Read more less

Book SynopsisDecision Making in Radiation Oncology is a reference book designed to enable radiation oncologists, including those in training, to make diagnostic and treatment decisions effectively and efficiently. The design is based on the belief that “a picture is worth a thousand words.” Knowledge is conveyed through an illustrative approach using algorithms, schemas, graphics, and tables. Detailed guidelines are provided for multidisciplinary cancer management and radiation therapy techniques. In addition to the attention-riveting algorithms for diagnosis and treatment, strategies for the management of disease at individual stages are detailed for all the commonly diagnosed malignancies. Clinical trials that have yielded “gold standard” treatment and their results are documented in the schemas. Moreover, radiation techniques, including treatment planning and delivery, are presented in an illustrative way. This groundbreaking publication is an essential tool for physicians in their daily clinical practice.Trade ReviewFrom the book reviews:“This is a comprehensive, full color atlas and text about various head and neck, breast, thoracic, and palliative care for oncology. … I highly recommend this book to oncologists, radiosurgeons, and physicians. … I heartily recommend this publication for all readers for a quick reference book.” (Joseph J. Grenier, Amazon.com, September, 2014)Table of ContentsVolume 1: Introduction .- Section I: Head and Neck Cancers: Orbital and Ocular Malignancies.- Nasopharyngeal Carcinoma.- Cancer of Oral Cavity and Oropharynx.- Malignant Tumors of the Major Salivary Glands.- Cancer of Larynx and Hypopharynx.- Squamous Cell Carcinoma of Unknown Head and Neck Primary.- Thyroid Cancer.- Section II: Breast Cancer: Breast Cancer.- Section III: Tumors of the Thorax: Lung Cancer (NSCLC & SCLC).- Thymoma.- Esophageal Cancer.- Section IV: Cancers of the Gastrointestinal Tract: Gastric Cancer.-Pancreatic Cancer.- Hepatobiliary Tumors.- Rectal Cancer .- Cancer of the Anal Canal.-Volume 2: Section V: Tumors of the Genitalurinary System: Cancer of the Bladder.- Cancer of the Prostate.- Testicular Cancer.- Section VI: Gynaecological Cancers: Endometrial Cancer.-Cancer of the Cervix.- Vulva Cancer.- Vaginal Cancer.- Section VII: Lymphomas: Non-Hodgkin’s Lymphoma.- Hodgkin’s Disease.- Multiple Myeloma and Plasmacytoma.-Cutaneous T-Cell Lymphoma.- CNS Lymphoma.- Section VIII: Tumors of the Central Nervous System: Meningioma.- Adult Glioma.- Pituitary Tumors.- Section IX: Skin Cancers and Soft Tissue Sarcoma: Skin Cancers including Melanoma.- Soft Tissue Sarcoma.- Section X: Pediatric Tumors: Pediatric CNS Tumors.- Retinoblastoma.- Neuroblastoma.- Ewing’s Sarcoma.- Wilm’s Tumor.- Section XI: Other: Palliative Radiation for Brain Metastasis.- Palliative Radiation for Bone Metastasis.- Appendix I: TD 5/5 (table).- Appendix II: Performance Status Scales.- Subject Index.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Book SynopsisWritten by internationally renowned experts, Clinical Ophthalmic Oncology provides practical guidance and advice on the diagnosis and management of the complete range of ocular cancers. The book supplies all of the state-of-the-art knowledge required in order to identify these cancers early and to treat them as effectively as possible. Using the information provided, readers will be able to provide effective patient care using the latest knowledge on all aspects of ophthalmic oncology, to verify diagnostic conclusions based on comparison with numerous full-color clinical photographs, and to locate required information quickly owing to the clinically focused and user-friendly format. This volume describes the classification, differential diagnosis, and imaging of orbital tumors and discusses the most suitable treatment options for different tumor types.​Trade Review“The volume covers all steps of the treatment process, from diagnostics reflections through surgical techniques and rehabilitation of the patient at the end of the medical treatment itself. The book consists of 19 chapters beginning with examination techniques and classification of orbital tumors. … The large number of clinical and histological images is of very high quality. … the second edition of ‘Orbital Tumors’ by Perry and Singh is a ‘must-read’ for all ophthalmologists treating patients with orbital diseases.” (Eckart Bertelmann, Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 254, 2016)Table of ContentsExamination Techniques.- Classification of Orbital Tumors.- Differential Diagnosis in Child.- Differential Diagnosis in Adults.- Imaging Techniques.- Non-Specific Orbital Inflammation.- Orbital Vascular Tumors.- Benign Orbital Tumors.- Optic Nerve Tumors.- Lacrimal Gland Tumors.- Lacrimal Sac Tumors.- Orbital and Adnexal Lymphoma.- Malignant Orbital Tumors.- Orbital Rhabdomyosarcoma.- Enucleation for Ocular Tumors.- Orbital Exenteration.- Principles of Orbital Surgery.- Orbital Implants.- Ocular Prosthesis.​

Read more less

Book SynopsisIn this volume an account is given of the technologies relevant to the detection of sentinel lymph nodes in the context of surgical oncology. This is a rapidly and evolving field, and the clinical applications discussed in this volume are exciting and important. A multidisciplinary team was assembled to discuss this subject in the light of direct experience gained by each of the groups in the previous 12 months. Clinical case material is presented and the methodology of sentinel lymph node imaging and detection is discussed in detail. The authors have assembled in a single volume a significant amount of personal data and a comprehensive literature review which will serve as a single reference and teaching source for all those interested in this critical technique relevant to the management of large numbers of patients in surgical oncology.Trade Review"...an excellent overview of a rather fashionable topic ...very didactic, with a wealth of colour pictures illustrating techniques, anatomy, histology and imaging procedures ...the contents are highly up-to-date and accurately report the data available today. I would recommend it to all surgeons, oncologists. histopathologists and nuclear medicine physicians." European Journal of Nuclear MedicineTable of Contents1. Sentinel Node Detection and Imaging 2. Radiopharmaceuticals 3. Radiation Detectors 4. How to choose a probe 5. Injection Techniques 6. Imaging Techniques 7. Surgical Techniques 8. Dosimetry and Radioation Protection 9. Histopathology of the Sentinel Node 10. Cytology of the Sentinel Node 11. Clinical Case Material 12. Malignant Melanoma: European Practice 13. Preliminary Study of Cost 14. The Future Subject index

Read more less

Table of Contentsof U.S.-Japan Joint Meeting on Phase I and II Clinical Trials.- The New NCI Screen and Its Implications for Clinical Evaluation.- The National Cancer Institute’s Natural Products Antineoplastic Development Program.- Methodology of Phase I Study in Japan.- Methodology of Phase II Clinical Trial in Cancer.- Phase II Study of Antineoplastic Agents in Japan.- Clinical Strategy for Evaluation of Anthracycline Analogues.- Preliminary Clinical Study of Aclacinomycin A.- Preclinical and Clinical Studies on Chlorozotocin, a New Nitrosourea with Decreased Bone Marrow Toxicity.- Continuation of Phase II Study of 1-(4-Amino-2-Methylpyrimidine-5-yl)-Methyl-3-(2-Chloroethyl)-3-Nitrosourea Hydrochloride (ACNU).- Review of Experimental Studies on Nitrosourea Derivates in Japan.- The Clinical Evaluation of Analogues, IV. Nitrosoureas.- Review of a New Antimetabolic Agent, 1-Hexylcarbamoyl-5-Fluorouracil (HCFU).- Review of a New Antimetabolic Agent, 1,1-Bis(Tetrahydro-2-Furanyl)-5-Fluoro-2,4-Pyrimidinedione (FD-1).- Effect and Mode of Action of N4-Behenoyl-?-D-Arabinofuranosylcytosine.- Strategy for Evaluation of a New Antitumor Agent in the Treatment of Breast Cancer.- Current Status of Breast Cancer Chemotherapy in Japan.- Present Status of Lung Cancer Chemotherapy in Japan.- Clinical Strategies in the Chemotherapy of Gastrointestinal Cancer.- Clinical Evaluation Strategy in Specific Disease Types — Clinical Study of Gastrointestinal Cancer Chemotherapy in One Institute of Japan.- A Review of Therapeutic Strategies for Phase I-II Trials in Genitourinary Cancer.- Recent Results of Using a Sequential Combination of Bleomycin and Mitomycin C in the Treatment of Metastatic Cervical Cancer.- Pharmacologic and Clinical Studies of N4-Behenoyl-1-Beta-D-Arabinofuranosylcytosine.

Read more less

Book SynopsisCarcinogenesis.- Inhalation Carcinogenesis: An Overview.- Lung Carcinogenesis During in Vivo Cigarette Smoking and Radon Daughter Exposure in Rats.- Epithelial Lesions Induced by Alpha Particles and Cigarette Smoke Condensates in Organotypic Culture of Human Bronchus.- Asbestos Carcinogenesis: Asbestos Interactions and Epithelial Lesions in Cultured Human Tracheobronchial Tissues and Cells.- Histogenesis.- The Contribution of Uranium Miners to Lung Cancer Histogenesis.- Pathogenesis of Bronchial Carcinoma, with Special Reference to Morphogenesis and the Influence on the Bronchial Mucosa of 20-Methylcholanthrene and Cigarette Smoking.- Lung Cancer Histogenesis Following in Vivo Bronchial Injections of 20-Methylcholanthrene in Dogs.- Localization of Occult Lung Cancer.- Bronchoscopie Localization of Radiologically Occult Cancer.- Hematoporphyrin Derivative as a Tumor Marker in the Detection and Localization of Pulmonary Malignancy.- Fluorescence Bronchoscopy for Localizing Early Bronchial Cancer and Carcinoma in Situ.- Fluorescence Fiberoptic Bronchoscopy in the Diagnosis of Early Stage Lung Cancer.- Results of Early Lung Cancer Detection Programs.- Results of a Lung Cancer Detection Program in an Asbestos Industry.- Lung Cancer Mortality in Males Screened by Chest X-ray and Cytologic Sputum Examination: A Preliminary Report.- Sputum Cytology and Asbestos Exposure: A Preliminary Report.- Lung Cancer Screening Programs in Canadian Uranium Mines.- Detection of Early and Roentgenologically Occult Bronchogenic Carcinoma: Preliminary Report of the Sabbatsberg Hospital Sputum Cytologic Screening Study.- Results of Lung Cancer Screening Programs in Japan.- Results of the Memorial Sloan-Kettering Lung Project.- Results of the Mayo Lung Project: An Interim Report.Table of ContentsCarcinogenesis.- Inhalation Carcinogenesis: An Overview.- Lung Carcinogenesis During in Vivo Cigarette Smoking and Radon Daughter Exposure in Rats.- Epithelial Lesions Induced by Alpha Particles and Cigarette Smoke Condensates in Organotypic Culture of Human Bronchus.- Asbestos Carcinogenesis: Asbestos Interactions and Epithelial Lesions in Cultured Human Tracheobronchial Tissues and Cells.- Histogenesis.- The Contribution of Uranium Miners to Lung Cancer Histogenesis.- Pathogenesis of Bronchial Carcinoma, with Special Reference to Morphogenesis and the Influence on the Bronchial Mucosa of 20-Methylcholanthrene and Cigarette Smoking.- Lung Cancer Histogenesis Following in Vivo Bronchial Injections of 20-Methylcholanthrene in Dogs.- Localization of Occult Lung Cancer.- Bronchoscopie Localization of Radiologically Occult Cancer.- Hematoporphyrin Derivative as a Tumor Marker in the Detection and Localization of Pulmonary Malignancy.- Fluorescence Bronchoscopy for Localizing Early Bronchial Cancer and Carcinoma in Situ.- Fluorescence Fiberoptic Bronchoscopy in the Diagnosis of Early Stage Lung Cancer.- Results of Early Lung Cancer Detection Programs.- Results of a Lung Cancer Detection Program in an Asbestos Industry.- Lung Cancer Mortality in Males Screened by Chest X-ray and Cytologic Sputum Examination: A Preliminary Report.- Sputum Cytology and Asbestos Exposure: A Preliminary Report.- Lung Cancer Screening Programs in Canadian Uranium Mines.- Detection of Early and Roentgenologically Occult Bronchogenic Carcinoma: Preliminary Report of the Sabbatsberg Hospital Sputum Cytologic Screening Study.- Results of Lung Cancer Screening Programs in Japan.- Results of the Memorial Sloan-Kettering Lung Project.- Results of the Mayo Lung Project: An Interim Report.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Book SynopsisIn the past 10 to IS years there has been dramatic improvement in the survival of children with acute lymphoblastic leukemia. At the present time, over 50% of children with this disease will be alive and free of their disease at least 5 years from the time of their initial diagnosis. Although a number of factors have contributed to this improvement, perhaps none has been as important as the institution of central nervous system preventive therapy (eNS prophylaxis). However, despite the efficacy of eNS prophylaxis, the prevention and treatment of central nervous system leukemia continues to pose a formidable clinical challenge to the pediatric oncologist. Although successful in most cases, eNS preventive therapy remains ineffective for a small but significant subset of patients at high risk for developing eNS disease. Moreover, it has become increasingly evident that some methods of eNS preventive therapy are associated with long-term, adverse eNS sequelae. Thus, considerable controversy exists regarding the optimal method of eNS prophylaxis. Treatment of the patient who develops overt meningeal leukemia has not been as successful and continues to pose a major clinical challenge. Despite the ability of intrathecal chemotherapy and/or radiation therapy to induce eNS remission, most patients suffer subsequent relapse and ultimate survival is usually signifi­ cantly compromised. It is evident that newer approaches to treatment for this patient group must be identified before major improvement for this patient group is likely to occur.Table of Contents1. The Pathology of Central Nervous System Leukemia.- 2. Radiation Therapy Methods for Central Nervous System ‘Prophylaxis’ in the Management of Childhood Leukemias.- 3. Central Nervous System Prophylaxis for Therapy of Acute Lymphocytic Leukemia.- 4. Reduction in Central Nervous System Leukemia with a Pharmaco-kinetically derived Intrathecal-Methotrexate Dosage Regimen.- 5. Central Nervous System Prophylaxis with Intermittent Intrathecal Methotrexate and Fractional Radiation in Childhood Acute Lymphoblastic Leukemia.- 6. Intermittent Intrathecal Methotrexate and Fractional Radiation plus Chemotherapy in Childhood Lymphoblastic Leukemia.- 7. Prophylaxis of Central Nervous System Leukaemia: British Experience, 1970–80.- 8. The Norwegian Methotrexate Study in Childhood Acute Lymphocytic Leukemia.- 9. Therapy Related Central Nervous System Diseases in Children with Acute Lymphocytic Leukemia.- 10. Neurotoxic Complications of CNS Prophylaxis in Childhood Leukaemia.- 11. Evaluation of Adverse Sequelae of Central Nervous System Prophylaxis in Acute Lymphoblastic Leukemia.- 12. Adverse Sequelae of Central Nervous System Prophylaxis in Acute Lymphoblastic Leukemia.- 13. Treatment of Overt CNS Leukaemia.- 14. Radiation Therapy Methods for the Treatment of Central Nervous System Leukemia.- 15. Treatment of Meningeal Leukemia: Investigation of New Approaches with Conventional Agents.

Read more less

Book SynopsisMagnetic resonance imaging has already become a most valuable imaging modality in the diagnostic work-up of musculoskeletal neoplasms. While high accuracy of MRI for staging purposes has been proven, we will focus in this monograph on the characterization of primary bone and soft tissue tumors by MRI. The major purpose of this monograph is to provide an atlas of magnetic resonance features of primary bone and soft tissue tumors for radiologists, orthopedic surgeons and physiotherapists. The results presented are based on investigations of 94 primary bone and soft tissue tumors and mimicking conditions by magnetic resonance imaging. Although the scale of the material allows for statistical handling, the number of patients per subgroup is too small to come to definite conclusions. We will therefore limit ourselves to the description of and comments on a great number of cases to illustrate the diagnostic potential of this new imaging modality. We would like to thank the anonymous cooperators: referring clinicians, pathologists, nurses, technicians and secretaries whose help enabled us to present this monograph. We would also like to express our gratitude to the firms Siemens AG and Schering AG for technical support.Table of Contents1 General Considerations about Bone and Soft Tissue Tumors.- 2 Materials and Methods.- Benign Bone Tumors and Mimicking Conditions.- 3 Osteoid Osteoma.- 4 Enchondroma.- 5 Osteochondroma.- 6 Giant Cell Tumor.- 7 Vertebral Hemangioma.- 8 Solitary Bone Cyst.- 9 Aneurysmal Bone Cyst.- 10 Non Ossifying Fibroma.- 11 Eosinophilic Granuloma.- 12 Fibrous Dysplasia.- 13 Osteomyelitis.- Malignant Bone Tumors.- 14 Osteogenic Sarcoma.- 15 Chondrosarcoma.- Benign Soft Tissue Tumors.- 16 Lipoma.- Neurogenic Tumor.- Soft Tissue Hemangioma.- Aggressive Fibromatosis.- Malignant Soft Tissue Tumors.- 17 Liposarcoma.- 18 Malignant Fibrous Histiocytoma.- 19 Rhabdomyosarcoma.- 20 Value of Contrast (Gd-DTPA)-Enhanced MRI Studies in Cases of Musculoskeletal Tumors.- 21 General Conclusions.

Read more less

Book SynopsisDespite the fact that the incidence of gastric cancer is declining in the Western world, it remains a significant problem with respect to accurate diagnosis and treatment since it has a high mortality rate. In June 1989 an International Conference was held at the University of Rome "La Sapienza" entitled "New Trends in Gastric Cancer: Background and videosurgery". During this meeting background information on the aetiopathogenesis of gastric cancer was presented together with talks and video presentations on the latest advances in the treatment of gastric carcinoma, both from the European and Japanese experience. Because of the poor prognosis of gastric carcinoma there is increasing pressure for early detection. Some of the problems in the early detection of gastric carcinoma are discussed together with methods of surveillance of high-risk subjects. It is generally accepted that the surgical approach to gastric carcinoma should take into account the site and extent of the lesion and there are chapters on new methods for pre and intraoperative staging of the disease which allow a more logical approach to surgery. A comparison between Japanese and Western rule and results was attempted and reasons for the differences were investigated. Since the field is still evolving not all aspects could be covered, and those angles not approached in this book will be addressed in a second International Conference to be held in Rome in June 1990.Table of ContentsSection 1 Background.- 1 Epidemiology and machanism of gastric carcinogenesis.- 2 Histiogenesis and precursors of human gastric cancer.- 3 N-nitroso compounds, gastric carcinogenesis and chemoprevention.- 4 Analytical problems in the determination of N-nitroso compounds in gastric juice.- 5 Early detection of patients at high risk of developing gastric cancer.- 6 Prospects for early detection of gastric cancer and precancerous lesions.- Section 2 New Trends in Diagnosis.- 7 New trends in electronic videoendoscopy of the digestive tract.- 8 Endosonography: its diagnostic utilities for gastric cancer.- 9 Flow cytometry in gastric cancer.- Section 3 Surgical Treatment of Gastric Cancer.- 10 Intraoperative staging in gastric cancer surgery.- 11 New technologies in gastric cancer surgery: Computer system to make operation plan and intraoperative staining of regional lymph nodes for complete dissection.- 12 The general rule of the Japanese Research Society for Gastric Cancer and treatment results by the rule.- 13 A European multicentre retrospective study in cancer of stomach.- 14 Surgical treatment of gastric cancer: our elective procedures for desirable curability.- 15 “Regional” gastrectomy.- 16 Total gastrectomy in the surgical treatment of gastric cancer.- 17 The role of extensive surgery in advanced gastric cancer.- 18 The importance of extended lymphadenectomy in gastric cancer surgery.- 19 Duodenopancreatectomy for gastric cancer.- 20 Reconstruction after total gastectomy.

Read more less